MRL-24

• Description :

  MRL-24 is a PPARγ agonist. MRL-24 can be used in metabolic disease related research[1].

• UNSPSC :

  12352005

• Target :

  PPAR

• Type :

  Reference compound

• Related Pathways :

  Cell Cycle/DNA Damage; Metabolic Enzyme/Protease; Vitamin D Related/Nuclear Receptor

• Applications :

  Neuroscience-Neuromodulation

• Field of Research :

  Cardiovascular Disease

• Assay Protocol :

  https://www.medchemexpress.com/mrl-24.html

• Purity :

  99.58

• Solubility :

  DMSO : 100 mg/mL (ultrasonic)

• Smiles :

  O=C(C1=CC=C(C=C1)OC)N2C(C(C(CC3=CC(O[C@@H](C)C(O)=O)=CC=C3)=C2C)=C4)=CC=C4OC(F)(F)F

• Molecular Formula :

  C28H24F3NO6

• Molecular Weight :

  527.49

• References & Citations :

  [1]Milton FA, et al. PPARγ partial agonist GQ-16 strongly represses a subset of genes in 3T3-L1 adipocytes. Biochem Biophys Res Commun. 2015 Aug 28;464 (3) :718-23.

• Shipping Conditions :

  Room Temperature

• Storage Conditions :

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• Isoform :

  PPARγ

• CAS Number :

  [393794-17-7]